Arkolith/Insider Trading/PLX/Form 4

Bashan Dror

PRESIDENT AND CEO, DirectorProtalix BioTherapeutics, Inc. (PLX) · full profile →Form 4 · filed Oct 20, 2023
Net Buying
Open-Market Buys
$90K
Open-Market Sells
$0
Net Open-Market Flow
$90K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 19, 2023Buy(P)16K$1.41$23K133K
Oct 19, 2023Buy(P)48K$1.40$68K116K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-014454) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML